scholarly article | Q13442814 |
P356 | DOI | 10.1194/JLR.M600312-JLR200 |
P698 | PubMed publication ID | 16971732 |
P50 | author | Aldons Jake Lusis | Q60642067 |
Rita M. Cantor | Q102307614 | ||
P2093 | author name string | Naoko Kono | |
Carla J H van der Kallen | |||
Marleen M J van Greevenbroek | |||
Tjerk W A de Bruin | |||
Martijn C G J Brouwers | |||
Monique A L Bilderbeek-Beckers | |||
Jeong Lim Yoon | |||
P2860 | cites work | Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results | Q29547377 |
Multipoint quantitative-trait linkage analysis in general pedigrees | Q29614967 | ||
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes | Q34370610 | ||
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels | Q34389639 | ||
Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia | Q34506656 | ||
Drugs and steatohepatitis | Q34643143 | ||
Complex trait locus linkage mapping in atherosclerosis: time to take a step back before moving forward? | Q36157757 | ||
Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice | Q37202331 | ||
Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans | Q40341458 | ||
Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity | Q43687653 | ||
The utility of radiological imaging in nonalcoholic fatty liver disease. | Q44116674 | ||
Biochemical and Genetic Association of Plasma Apolipoprotein A-II Levels With Familial Combined Hyperlipidemia | Q44435209 | ||
Confirmed Locus on Chromosome 11p and Candidate Loci on 6q and 8p for the Triglyceride and Cholesterol Traits of Combined Hyperlipidemia | Q44590583 | ||
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). | Q44780711 | ||
Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees | Q45016524 | ||
Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia | Q46526322 | ||
Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. | Q46564935 | ||
Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis | Q46572787 | ||
USF1 and dyslipidemias: converging evidence for a functional intronic variant | Q46632174 | ||
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease | Q46685325 | ||
Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. | Q47411130 | ||
Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia | Q47426824 | ||
A genome-wide scan for body mass index among Nigerian families. | Q50645302 | ||
Further Evidence for a QTL Influencing Body Mass Index on Chromosome 7p from a Genome-wide Scan in Dutch Families | Q57700162 | ||
P433 | issue | 12 | |
P921 | main subject | hyperlipidemia | Q1079120 |
heritability | Q1503548 | ||
P304 | page(s) | 2799-2807 | |
P577 | publication date | 2006-09-13 | |
P1433 | published in | Journal of Lipid Research | Q6295449 |
P1476 | title | Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. | |
P478 | volume | 47 |
Q37259440 | Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort |
Q40433596 | Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study |
Q39358760 | Epigenetics and Liver Fibrosis |
Q28079271 | Epigenetics in liver disease: from biology to therapeutics |
Q36411266 | Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population |
Q34173360 | Genetic copy number variants in myocardial infarction patients with hyperlipidemia. |
Q34646183 | Genetic determinants of hepatic steatosis in man. |
Q37362755 | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. |
Q42362575 | Genetics of common obesity and nonalcoholic fatty liver disease |
Q30368624 | Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study |
Q90468697 | Incidence of type 2 diabetes in familial combined hyperlipidemia |
Q24563068 | Non-alcoholic fatty liver disease: what the clinician needs to know |
Q45285715 | PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations. |
Q34636684 | Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets |
Q88017549 | Prospective associations of dietary carbohydrate, fat, and protein intake with β-cell function in the CODAM study |
Q47265933 | Relationship between Genetic Variation at PPP1R3B and Liver Glycogen and Triglyceride Levels |
Q37384502 | Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study |
Q40528724 | Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study |
Q64081318 | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease |
Q57415496 | The cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study) |
Q37569347 | The genetic architecture of liver enzyme levels: GGT, ALT and AST. |
Q37983699 | The genetics of familial combined hyperlipidaemia |
Q84286506 | sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease |
Search more.